Boston Partners’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-45
Closed -$2K 713
2019
Q4
$2K Hold
45
﹤0.01% 696
2019
Q3
$2K Buy
+45
New +$1.89K ﹤0.01% 705
2017
Q3
Sell
-325,311
Closed -$20.4M 774
2017
Q2
$20.4M Sell
325,311
-183,839
-36% -$10.5M 0.03% 311
2017
Q1
$28.3M Sell
509,150
-11,533
-2% -$594K 0.04% 277
2016
Q4
$24.9M Sell
520,683
-224
-0% -$12.5K 0.03% 304
2016
Q3
$33.7M Buy
520,907
+35,680
+7% +$2.01M 0.05% 260
2016
Q2
$22.4M Buy
485,227
+4,244
+0.9% +$171K 0.03% 290
2016
Q1
$18.4M Sell
480,983
-1,843
-0.4% -$61K 0.03% 304
2015
Q4
$18.3M Buy
482,826
+21,613
+5% +$796K 0.03% 311
2015
Q3
$19M Buy
461,213
+8,447
+2% +$363K 0.03% 295
2015
Q2
$21.3M Buy
452,766
+67,806
+18% +$3.67M 0.03% 293
2015
Q1
$23.2M Sell
384,960
-15,572
-4% -$793K 0.03% 278
2014
Q4
$17.5M Sell
400,532
-25,585
-6% -$1.13M 0.03% 320
2014
Q3
$19.2M Buy
426,117
+236,152
+124% +$12.6M 0.03% 287
2014
Q2
$14.1M Sell
189,965
-838
-0.4% -$66K 0.02% 337
2014
Q1
$15.8M Sell
190,803
-61,916
-24% -$5.44M 0.03% 328
2013
Q4
$34.9M Sell
252,719
-146,201
-37% -$17.2M 0.07% 215
2013
Q3
$38.2M Sell
398,920
-331,227
-45% -$28.1M 0.09% 196
2013
Q2
$44.6M Buy
+730,147
New +$40.5M 0.12% 162

Other funds holding NUS

Boston Partners's NUS Position: Q1 2020 in Review

Boston Partners sold out of Nu Skin (NUS) in Q1 2020, closing a stake of 45 shares — an estimated $2K sold.

Boston Partners first reported a position in NUS in Q2 2013 and held it in 19 quarters. The position peaked at $44.6M in Q2 2013. 199 funds tracked by Wall St. Rank hold NUS as of Q1 2020.

  • Boston Partners reported no remaining Nu Skin position as of Q1 2020 after selling out during the quarter.
  • Boston Partners sold 45 Nu Skin shares in Q1 2020, an estimated $2K.
  • Boston Partners first reported a position in Nu Skin in Q2 2013 and held it in 19 quarters.
  • Boston Partners's Nu Skin position peaked at $44.6M in Q2 2013.
  • 199 funds tracked by Wall St. Rank held Nu Skin as of Q1 2020.

Based on Boston Partners's 13F filing for Q1 2020, filed 13 May 2020.